193 related articles for article (PubMed ID: 18178090)
1. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Damiani F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Perini O; Petrone M; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):908-12. PubMed ID: 18178090
[TBL] [Abstract][Full Text] [Related]
2. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Celestini P; Damiani F; Di Fabio R; Donati D; Gagliardi S; Gentile G; Hamprecht D; Petrone M; Radaelli S; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):901-7. PubMed ID: 18248991
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives. herve.geneste@abbott.com.
Geneste H; Backfisch G; Braje W; Delzer J; Haupt A; Hutchins CW; King LL; Lubisch W; Steiner G; Teschendorf HJ; Unger L; Wernet W
Bioorg Med Chem Lett; 2006 Feb; 16(3):658-62. PubMed ID: 16271293
[TBL] [Abstract][Full Text] [Related]
4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: variations on the 1H-pyrimidin-2-one theme.
Geneste H; Amberg W; Backfisch G; Beyerbach A; Braje WM; Delzer J; Haupt A; Hutchins CW; King LL; Sauer DR; Unger L; Wernet W
Bioorg Med Chem Lett; 2006 Apr; 16(7):1934-7. PubMed ID: 16439127
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: 1H-pyrimidin-2-one derivatives.
Geneste H; Backfisch G; Braje W; Delzer J; Haupt A; Hutchins CW; King LL; Kling A; Teschendorf HJ; Unger L; Wernet W
Bioorg Med Chem Lett; 2006 Feb; 16(3):490-4. PubMed ID: 16290141
[TBL] [Abstract][Full Text] [Related]
7. Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists.
Zhu Z; Sun ZY; Ye Y; McKittrick B; Greenlee W; Czarniecki M; Fawzi A; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2009 Sep; 19(17):5218-21. PubMed ID: 19643610
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.
Wu WL; Burnett DA; Spring R; Greenlee WJ; Smith M; Favreau L; Fawzi A; Zhang H; Lachowicz JE
J Med Chem; 2005 Feb; 48(3):680-93. PubMed ID: 15689153
[TBL] [Abstract][Full Text] [Related]
9. Remote functionalization of SCH 39166: discovery of potent and selective benzazepine dopamine D1 receptor antagonists.
Sasikumar TK; Burnett DA; Greenlee WJ; Smith M; Fawzi A; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2010 Feb; 20(3):832-5. PubMed ID: 20064718
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
[TBL] [Abstract][Full Text] [Related]
11. Parallel synthesis and biological screening of dopamine receptor ligands taking advantage of a click chemistry based BAL linker.
Bettinetti L; Löber S; Hübner H; Gmeiner P
J Comb Chem; 2005; 7(2):309-16. PubMed ID: 15762761
[TBL] [Abstract][Full Text] [Related]
12. GPCR targeted library design: novel dopamine D3 receptor ligands.
Böcker A; Sasse BC; Nietert M; Stark H; Schneider G
ChemMedChem; 2007 Jul; 2(7):1000-5. PubMed ID: 17477344
[No Abstract] [Full Text] [Related]
13. Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists.
Qiang L; Sasikumar TK; Burnett DA; Su J; Tang H; Ye Y; Mazzola RD; Zhu Z; McKittrick BA; Greenlee WJ; Fawzi A; Smith M; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2010 Feb; 20(3):836-40. PubMed ID: 20061148
[TBL] [Abstract][Full Text] [Related]
14. [3-azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonists.
Micheli F; Hamprecht D; Bonanomi G; Di Fabio R; Donati D; Gentile G; Heidbreder C; Prandi A; Tarsi L; Terreni S
Bioorg Med Chem Lett; 2010 Sep; 20(18):5491-4. PubMed ID: 20692836
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.
Holmes IP; Micheli F; Gaines S; Lorthioir O; Watson SP; Fabio RD; Gentile G; Heidbreder C; Savoia C; Worby A
Bioorg Med Chem Lett; 2009 Aug; 19(16):4799-801. PubMed ID: 19560918
[TBL] [Abstract][Full Text] [Related]
16. 1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.
Micheli F; Arista L; Bonanomi G; Blaney FE; Braggio S; Capelli AM; Checchia A; Damiani F; Di-Fabio R; Fontana S; Gentile G; Griffante C; Hamprecht D; Marchioro C; Mugnaini M; Piner J; Ratti E; Tedesco G; Tarsi L; Terreni S; Worby A; Ashby CR; Heidbreder C
J Med Chem; 2010 Jan; 53(1):374-91. PubMed ID: 19891474
[TBL] [Abstract][Full Text] [Related]
17. Hydrazides of clozapine: a new class of D1 dopamine receptor subtype selective antagonists.
Sasikumar TK; Burnett DA; Zhang H; Smith-Torhan A; Fawzi A; Lachowicz JE
Bioorg Med Chem Lett; 2006 Sep; 16(17):4543-7. PubMed ID: 16809034
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of aminothiazole fused benzazepines as selective dopamine D2 partial agonists.
Urbanek RA; Xiong H; Wu Y; Blackwell W; Steelman G; Rosamond J; Wesolowski SS; Campbell JB; Zhang M; Brockel B; Widzowski DV
Bioorg Med Chem Lett; 2013 Jan; 23(2):543-7. PubMed ID: 23237836
[TBL] [Abstract][Full Text] [Related]
19. SB-277011 GlaxoSmithKline.
Remington G; Kapur S
Curr Opin Investig Drugs; 2001 Jul; 2(7):946-9. PubMed ID: 11757796
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.
Giri R; Namballa HK; Sarker A; Alberts I; Harding WW
Bioorg Med Chem Lett; 2020 Aug; 30(16):127305. PubMed ID: 32631525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
